4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮，CAS 登记号 327036-89-5，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于有机化学品。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
有机化学品
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 4-苄基-2-甲基-1,2,4-噻二唑烷-3,5-二酮 的 CAS 号：327036-89-5，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及有机化学品。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione · CAS 327036-89-5 · C10H10N2O2S. UNII HMS3229G12.
| CAS Registry Number | 327036-89-5 |
|---|---|
| PubChem CID | 4124851 |
| Molecular formula | C10H10N2O2S |
| IUPAC name | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione |
| UNII (FDA) | HMS3229G12 |
| Molecular Weight | 222.27 |
|---|---|
| XLogP3 | 1.5 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 222.04629874 |
| Monoisotopic Mass | 222.04629874 |
| Topological Polar Surface Area | 65.9 |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Reported hazard statements | H334 (97.4%) |
|---|
H334 (97.4%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory]
P233, P260, P271, P284, P304+P340, P342+P316, P403, and P501 (click each P-code to see the statement)
TDZD-8; 327036-89-5; 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione; thiadiazolidinone-8; CHEBI:147411; DTXSID30399590; RefChem:97970; DTXCID10350447; 636-505-3; GSK-3beta Inhibitor I; TDZD 8; 1,2,4-Thiadiazolidine-3,5-dione, 2-methyl-4-(phenylmethyl)-; NP 01139; MFCD04973552; TDZD8; BDBM7781
CAS 327036-89-5; molecular formula C10H10N2O2S; molecular weight — g/mol.
TDZD-8, 327036-89-5, 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione, thiadiazolidinone-8, CHEBI:147411, DTXSID30399590.
Hazard statements reported: H334.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.